NCT07182851

Brief Summary

Introduction: Pain is a subjective symptom, a physiological response that is difficult to assess, which affects the body physically and/or emotionally. It is a common phenomenon among clinical and surgical patients in Intensive Care Units (ICU). And its effects are the combined results of physiological and behavioral aggressions caused by clinical conditions, immobility and the execution of common procedures in ICU's. The presence of pain appears to be independently associated with worse clinical outcomes, including higher infection rates, patient-ventilator asynchronies, delirium, prolonged mechanical ventilation (MV), length of hospital stay and higher healthcare costs. Objectives: To evaluate the prevalence of pain and its associated factors in mechanically ventilated surgical patients in ICU's. Methods: This is a cohort, prospective, multicenter study designed to estimate the prevalence of pain, its intensity, its associated factors, correlating them to outcomes such as patient-ventilator asynchrony rate, time to weaning, and 28-day mortality in mechanically ventilated patients. All research participants who meet the inclusion criteria and who are not using neuromuscular blockers, or have any other condition associated with altered pain perception, will be evaluated using the Behavioral Pain Scale (BPS) and the Critical Care Pain Observation Tool (CPOT) on the 2nd day of mechanical ventilation and on the first day of awakening, when the RASS scale is between 4 and -2. At the same time, data will be collected on the ongoing sedoanalegesia strategy, and the asynchrony index will be calculated \[(Nº of asynchronous ventilatory cycles/Nº of ventilatory cycles studied) \*100\]. The end point of the research will be 28 days, where the time until weaning, time until discharge or death will be established using the Kaplan-Meier estimators. Expected results: The prevalence of pain and its intensity is associated with the presence of patient-ventilator asynchronies and thus with harsh outcomes related to the length of stay in the ICU, time until weaning and thirty-day mortality in the ICU. It is estimated that there is agreement between the BPS and CPOT scales in mechanically ventilated patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
370

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2025

Shorter than P25 for all trials

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2025

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

June 3, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

September 19, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2026

Completed
Last Updated

September 19, 2025

Status Verified

June 1, 2025

Enrollment Period

7 months

First QC Date

June 3, 2025

Last Update Submit

September 17, 2025

Conditions

Keywords

mechanical ventilationintensive care unitPain Assessment

Outcome Measures

Primary Outcomes (2)

  • Pain Intensity by BPS

    The intensity of pain will be assessment by Behavioral Pain Scale (BPS) in the morning, after the first tracheal suctioning procedure.

    From second day after enrollment , from first day at RASS -2 or minus, with end point 28 - day.

  • Pain intensity by CPOT

    The intensity of pain will be assessment by Critical care pain observation tool (CPOT) in the morning after the first tracheal suctioning procedure.

    Time Frame: From second day after enrollment , from first day at RASS -2 or minus, with end point 28 - day.

Secondary Outcomes (6)

  • Ventilatory Settings

    From second day after enrollment, from first day at RASS-2 or minus, with end point 28-day"

  • Airway occlusion pressure(P0.1)

    This measurement will be taken on the second day of mechanical ventilation and on the first day after reduction or suspension of sedation in which the patient assumes a RASS -2 or less. The study endpoint will be in 28 days.

  • Patient-mechanical ventilator asynchrony index

    This asynchrony index will be measured on the second day of mechanical ventilation and on the first day after suspension or reduction of sedation with the participant assuming a RASS-2 or less. The study endpoint will be 28 days.

  • 28-day mortality

    28 days

  • Duration of mechanical ventilation

    Up to 28 days or hospital discharge, whichever occurs first

  • +1 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patientes admitted in ICU's in use of invasive mechanical ventilation

You may qualify if:

  • Participants of both sexes, aged 18 or over;
  • Participants who are using invasive mechanical ventilation,

You may not qualify if:

  • Participants undergoing treatment with neuromuscular blockers,;
  • Participants with any condition associated with altered pain perception (e.g., Guillain-Barré Syndrome, SCI, etc.);
  • Participants with any condition that would likely interfere with behavioral assessments of pain (e.g., decortication or decerebration posture)
  • As the assessments will be carried out before and after the tracheal aspiration procedure, if the patient does not have objective criteria for tracheal aspiration, he/she will be excluded from the study, irrefutably preventing the procedure from being carried out without express need.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Hospital Central da Aeronáutica

Rio de Janeiro, Rio de Janeiro, Brazil

RECRUITING

Hospital Central da Polícia Militar do Estado do Rio de Janeiro

Rio de Janeiro, Rio de Janeiro, Brazil

RECRUITING

Hospital Universitário Clementino Fraga Filho

Rio de Janeiro, Rio de Janeiro, Brazil

RECRUITING

Hospital Universitário Gafrée Guinle

Rio de Janeiro, Rio de Janeiro, Brazil

RECRUITING

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Arthur S Ferreira, Dsc

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 3, 2025

First Posted

September 19, 2025

Study Start

June 1, 2025

Primary Completion

December 20, 2025

Study Completion

March 31, 2026

Last Updated

September 19, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

You data of present study will be available through of one universal data repository, in addition to the virtual library and database of UNISUAM and each center participating in the study

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
From december 2025 for 5 five years

Locations